CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Ropivacaine +1 moredrug
Likely dose
Ropivacaine 1.5 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00680823
NCT00680823N/ACompleted
CompareCT.gov

Is Paraspinal Intramuscular Ropivacaine Injection an Effective Treatment for Headache in a Pediatric Emergency Department?

Robert Hickey·interventional·Posted May 20, 2008·Updated Feb 26, 2018

In Brief

A clinical study evaluating Ropivacaine and Normal saline for Headache and Migraine. Completed, enrolled 150 participants across 1 site.

Detailed Summary

Objective: To determine if lower paracervical intramuscular ropivacaine injection is an effective treatment for pediatric headache in an emergency department setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeadache, Migraine
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 20, 2008
Enrollment StartJan 1, 2009
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7.4 yearsPosted 18.1 years ago

Interventions

Ropivacainedrug

1.5 mL IM to each side in to the lower cervical paraspinous muscles x 1.

Normal salinedrug

1.5 mL IM to each side in to the lower cervical paraspinous muscles x 1.